Plasma renin activity in anesthetized rats after short periods of reduced renal blood flow (ischemia), 1976 by West, Eugene (Author) & Myers, Joseph B. (Degree supervisor)
PLASMA RENIN ACTIVITY IN ANESTHETIZED RATS AFTER SHORT
PERIODS OF REDUCED RENAL BLOOD FLOW (ISCHEMIA)
A THESIS
SUBMITTED TO THE FACULTY OF ATLANTA UNIVERSITY
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS















Dean, School of Arts and Sc
ABSTRACT
BIOLOGY
WEST, EUGENE B.S., Tennessee A & I State University, 1968
Plasma Renin Activity in Anesthetized Rats After Short Periods of
Reduced Renal Blood Flow (Ischemia)
Advisor: Dr. Joseph B. Myers
Master of Science degree conferred May 17, 1976
Thesis dated May, 1976
This investigation was conducted to determine plasma renin
activity (PRA) in acute renal ischemic rats (Sprague-Dawley) and spon
taneously hypertensive rats (SHR, Wistar strain). Sodium concentra
tions of plasma and urine were measured for possible correlation with
PRA.
Acute experimental renal ischemia was induced in male normoten-
sive (blood pressure < 150 mm Hg) Sprague-Dawley rats ranging in weight
from 141 to 397 g by the partial constriction of the left renal artery
and removing the contralateral kidney or leaving the contralateral
kidney intact, for one-kidney and two-kidney ischemic rats respectively.
One-kidney control rats had the left kidney intact and the contra
lateral kidney removed. Two-kidney control rats had both kidneys
intact and no constriction.
SHR's developed hypertension spontaneously between the age of six
to ten weeks. Rats with systolic blood pressures above 150 mm Hg were
considered to be hypertensive. Eleven male SHR's and five normotensive
Wistar males were used as controls for the essential hypertension study.
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The SHR's had a mean weight, blood pressure and age of 269.91 ± 1.14 g,
182.11 ± 6.28 mm Hg and 33 weeks respectively.
Nine Sprague-Dawley control rats were nephrectomized 24 hours
before plasma samples were collected. Ten normotensive Sprague-Dawley
rats were used to ascertain normal PRA values. This phase of the in
vestigation tested the validity of the assay procedure and compared
the PRA of anephric controls and normotensive rats with the two experi
mental systems (one-kidney and two-kidney ischemic rats).
Plasma and urine samples were collected from individual test
animals and their controls at 10, 30, 60 and 90 min to establish pro
files. SHR's, Wistar controls, anephric controls, and normotensive
Sprague-Dawley rats had plasma samples collected after being anesthe
tized (zero time). Rat plasma (1.0 ml) was incubated (for 1 hr at 37 C)
at pH 6.5 and the generated angiotensin-I was determined by radioimmuno-
assay. Kidney weights of all animal groups were recorded since possible
change in renal mass may affect PRA.
It was concluded from our observations and other supportive data
that PRA in acute ischemia varies considerably. However, an increase
in PRA occurred as the timed intervals increased. SHR's demonstrated
that their associated high blood pressure may function independently of
the renin-angiotensin system. The assay procedure for PRA was validated
by a comparative analysis of plasma from anephric and normotensive
Sprague-Dawley rats. No direct correlations were established for plasma
or urine sodium concentrations and PRA. In addition, kidney mass was
found to influence PRA.
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Bright (1836) first described the association of contracted kid
neys with hypertrophied left ventricles. The left ventricular hyper
trophy was soon correctly recognized as a concomitant of increased
arterial blood pressure, and the kidneys were considered to be the
center of the disturbance. This significant observation has led to
numerous investigations relative to the role of the kidney in the
pathophysiology of hypertension.
In the latter part of the nineteenth century, the ideas of
Brown-Sequard on the internal secretion of chemical substances into
the bloodstream came to have a considerable influence on physiological
thought and work concerning hypertension. To date, enough data has
accumulated to force a serious consideration of the dual, opposing
effects (hypertensive and antihypertensive) of the kidney on blood
pressure. The two roles are believed to be related to the ability of
one of the medullary vasodepressor lipids to antagonize specifically
the hypertensive action of the renin-angiotensin system.
Goldblatt et al. (1934) reported that if the blood flow to the
kidney was restricted (by a Goldblatt clamp on the renal artery) the
kidney will secrete into circulation a substance or substances (renin,
angiotensin) that tend to raise the central blood pressure to levels
far above normal, thereby overriding the reflex control of aortic
blood pressure and creating a condition called renal hypertension.
This rise of blood pressure may well protect the tissues of the affected
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kidney by increasing its blood flow toward normal. It has been found
that the cells of the clamped kidney are much less affected by the
ischemia than would be expected (Burton, 1972). However, cells of the
remainder of the body may eventually suffer pathological changes due to
an increase in blood pressure caused by the renin-angiotensin system.
Renal hypertension appears to be due to an encroachment upon the
blood flow of a renal artery (usually extrarenal but occasionally intra-
renal) which is associated with an increased secretion of renin. Due
to a reduction in renal function, an ensuing elevation of blood pressure
takes place. Essential hypertension describes yet unidentified physio
logical disturbances which result ultimately in an elevation of diastolic
and systolic blood pressures. Also, anatomical changes occur in the
vascular tree along with functional impairment of target tissues
(Goldring, 1951).
The role of the kidney in the regulation of blood pressure
through the secretion of a proteolytic enzyme was first suggested by
Goldblatt (1934). Since then, the interrelations of the different
components of the renin-angiotensin system have become known, and it is
now clear that renin is not only involved in homeostatic control mechan-
isma of blood pressure but also plays an important role in the patho-
genesis of certain hypertensive diseases. Because of this, quantitative
laboratory renin determinations of peripheral and renal venous blood
have become important in the diagnosis of hypertension.
The biological activity of the renin-angiotensin system begins
with the proteolytic enzyme renin which is stored in specialized
juxtaglomerular cells within the walls of the afferent arterioles of the
glomeruli. The enzyme has a molecular weight of approximately 40,000
and has no vasoconstrictive or pressor properties in itself. However,
renin does act upon angiotensinogen (renin substrate), an alpha-2-
globulin manufactured in the liver and present in circulating blood.
Renin acts on its substrate by hydrolyzing the leucine-to leucine bond
to yield a decapeptide fragment from the substrate molecule. This
decapeptide, angiotensin-I, has an extremely weak vasoconstrictive
action but may be important in the stimulation of aldosterone synthesis
in the adrenal cortex.
Angiotensin-I, during its circulation through the lung and the
kidney, is acted upon further by a converting enzyme which removes the
two terminal amino acids to produce an octapeptide, angiotensin-II.
This octapeptide is an extremely potent vasoconstrictive pressor sub
stance. Circulating levels of angiotensin-II are kept in balance by
the presence of various angiotensinases which further degrades the
molecule into inactive fragments.
The smooth muscle of the arterioles collectively appear to be
the final link in the chain; this muscle responds to angiotensin-II by
contraction resulting in an increased peripheral blood pressure which
may serve as a homeostatic function. If a hierarchy of homeostatic
functions were considered, it is expected that all the factors such as
renin, aldosterone, adrenergic activity and other hormones must share
some final common path in the initiation of hypertension. This final
common path may be the total body sodium and can usually be related to
the serum sodium and plasma sodium regardless of the elevated blood
pressure. Sodium repletion usually depresses renin and aldosterone in
the normal and hypertensive state. Renin secretion might well be a
mechanism that the kidney utilizes to maintain perfusion pressure and
thereby carry out essential kidney functions during disease or stress
conditions.
The purpose of this investigation was: (1) to formulate a
reliable procedure for the determination of renin activity, (2) to
compare plasma renin activity in acute renal ischemic and essential
hypertensive rats, and (3) to correlate urine and plasma sodium levels
with plasma renin activity during reduced renal blood flow in two
experimental systems.
CHAPTER II
* REVIEW OF LITERATURE
The late 1890's was the initial era of research into internal
chemical secretions affecting distant organs. Bright (1836) reasoned
that an altered quality of the blood might be responsible for the
thickening of the heart muscle (i.e. hypertension). At this time, the
search began for an internal secretion released from the kidney that
could affect blood pressure. This observation is now 137 years old
but the mechanism by which the kidney affects the cardiovascular system
is still far from being understood.
Tigerstedt and Bergman: (1898) investigated a possible endocrine
function of the kidney. They demonstrated that the injection of a crude
saline extract of rabbit kidneys into anesthetized rabbits raised the
arterial blood pressure thereby producing a pressor response. Since
the active substance in their extracts caused vasoconstriction, they
named it renin.
Approximately 36 years after its discovery, renin was still only
a curiosity and a matter for dispute; no particular attention was paid
to the significance of renin perhaps because the idea of primary (non-
renal) hypertension was dominant. Pearce (1909) and Hartwich and Hessel
(1932) were unable to confirm the pressor effect of renin. However,
Vincent and Sheen (1903), Shaw (1906), and Bingel and Strauss (1909)
were able to repeat the pressor affect. Difficulties may have been due
to the use of alcohol at room temperature as an extractant as this is
known to denature renin. There may well have been depressor substances
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and bacterial products present in some of the extracts.
The significant work of Goldblatt et al. (1934) showed that a
persistent rise in blood pressure could be produced in the dog by con
stricting a renal artery. Goldblatt's experiment not only resurrected
the forgotten enzyme renin, but also led to some of the modern concepts
of hypertensive disorders.
This work stimulated several groups of investigators to re-
examine the nature of the substance that might cause renal hypertension
(Pickering and Prinzmental, 1938; Hessel, 1938; Helmer and Page, 1939;
Swingle et al., 1939).
Pickering and Prinzmental (1938) produced a prolonged rise of
blood pressure by intravenous injection of extracts prepared from fresh
kidneys. The active substance was present in the cortex but not in the
medulla of the kidney.
Initially endocrine, neurogenic, and humoral mechanisms were
considered as precursors of hypertension although appropriate experi
ments quickly narrowed these choices. Endocrine ablation studies or
sympathoctomies proved unable to prevent the hypertension but occlusion
of the renal vein did avert the blood pressure elevation. Thus, it was
a substance transported into general circulation via the renal vein,
which caused the development of hypertension. The humoral factor was
subsequently identified as renin, the same material discovered and
given little significance 36 years earlier.
Goldblatt (1934) hypothesized that essential hypertension was a
disease in which blood pressure elevation appeared first, and second
arily involved small blood vessels throughout the body, including those
in the kidney. More specifically, nephrosclerosis was the result of
elevated blood pressure. Pathological studies on hypertensive indi
viduals revealed far more frequent and severe blood vessel involvement
in the kidney than in any other organ. Although Goldblatt acknowledged
that blood vessels in the kidney could be more vulnerable to the
effects of hypertension than vessels in other organs, other possibili
ties aroused his interests. Goldblatt questioned whether nephrosclerosis
was a primary event that led to the development of hypertension or
whether essential hypertension was of renal origin. Similar questions
were voiced by Bright in the early 19th century.
To test this hypothesis experimentally, it was necessary to
produce nephrosclerosis in a normotensive organism and thereafter follow
the course of the increased blood pressure. Goldblatt's first great
accomplishment was the design of a clamp which could be left on the
renal artery for days or months and whose degree of constriction could
be increased or decreased at will. Using this procedure, a two-stage
experiment was designed. First, one renal artery would be partially
constricted, and several weeks later the other artery would be similarly
constricted. Because of the interval between the two stages, the
effects of unilateral renal artery constriction in dogs could be ob
served for several weeks. These experiments demonstrated that blood
pressure elevation could be produced from unilateral renal artery con
striction. Goldblatt further demonstrated that this type of elevated
blood pressure could be returned to normal by removing either the renal
arterial clamp or the kidney whose artery was constricted. Thus, by a
most fortunate accident of experimental design, the laboratory
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production of hypertension by unilateral renal constriction and the re
lief of that hypertension by restoration of the renal blood flow were
both significant findings. The primary objective of Goldblatt's experi
ments was to prove that essential hypertension was of renal origin, but
based on the results (previously mentioned), this hypothesis was quickly
forgotten.
To date, the elucidation of the renin-angiotensin system owes
much to these initial findings and many other factors are now known to
influence this system. McCance and Widdowson (1936) reported that plasma
volume decreased during sodium deprivation, while juxtaglomerular cells
hypertrophy (Hartroft and Hartroft, 1953; Tobian et al., 1958; Newmark
et al., 1959) and the renin content in circulating plasma also increased
(Brown et al., 1964). Conversely, sodium loading leads to an increase in
plasma volume, a decrease in size and granularity of the juxtablomerular
cells and the decrease in plasma renin (Lyons et al., 1944; Hartroft
and Edelman, 1960).
The true stimulus of renin release is unknown. Brown et al. (1965)
indicated that the renin-angiotensin system might play an important role
in the maintenance of sodium balance. Consequently, sodium may well be
a stimulus to this system.
Initially, a number of bioassay methods were developed for the
determination of angiotensin-II. One of the first was that of Skeggs
et al. (1953) using a rat blood pressure preparation. Boucher et al.
(1967) modified this method and it was later adapted for more practical
and rapid application by Gunnells et al. (1967). However, despite the
usefulness of these methods, bioassay of plasma renin activity (PRA)
never gained widespread use because of the complexity of the assay
system.
Haber et al. (1965) and Goodfriend et al. (1966) first reported
the use of radioimmunoassay methods for angiotensin-II. However,
Haber et al. (1969) later reemphasized the physiological and patho-
physiological significance of renin determinations and described the
advantages of a radioimmunoassay procedure for direct estimation of the
primary product of renin activity, angiotensin-I. Under the conditions
of this assay, plasma renin reagents must inhibit the plasma-converting
enzyme and angiotensinases. Thus, the radioimmunoassay provided
additional impetus toward the study of the renin-angiotensin-aldosterone
system in order to better understand renovascular hypertension and
primary aldosteronism.
According to the literature, it seems that there is no one process
that leads to hypertension; therefore, a number of processes, physico-
chemical and biological, are involved in the pathophysiology of hyper
tension and the renin-angiotensin system.
CHAPTER III
MATERIALS AND METHODS
Only male rats were used in this investigation. They were
obtained from the following sources: Sprague-Dawley rats and normo-
tensive Wistar controls, ARS Sprague-Dawley, Madison, Wisconsin; Spon
taneous Hypertensive Wistar rats (SHR), Carsworth Farms, Portage,
Michigan. Animals were maintained on a standard diet of Purina labora
tory chow and water jad libitum.
Systolic blood pressure was monitored on all animals using a
programmed electrosphygomomanometer and pneumatic pulse transducer
connected to a Physiograph recorder (Narco Bio-Systems Inc., Houston,
Texas).
Sodium concentrations for both urine and plasma were determined
by Atomic Absorption Spectrophotometer, Model 107 (Perkin-Elmer,
Norwalk, Connecticut) with the instrument in the emission mode.
Angiotensin-I 125j radioimmunoassay kits and radioimmunofluor
(Aquasol) were obtained from New England Nuclear, Biochemical Assay
Laboratories, Worchester, Massachusetts. All counts were determined




Preparatory and surgical procedures were as follows: All animals
were weighed and anesthetized with pentobarbital sodium (Nembutal,
10
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30 ing/kg of body wt). A ventral mid-line incision was made along the
linea alba to open the peritoneal cavity. The aorta and vena cava
were exposed and dissected free of other tissue in the lower abdominal
region in order to collect blood samples. All operations were done
under aseptic conditions.
A modification of the Goldblatt clamp was used because the rats
varied in body weights. The modified clamp consisted of a piece of
chromel wire (0.33 mm O.D.) placed within a loop of suture (#000)
surrounding the left renal artery. The suture thread was again looped,
tied, and the chromel wire carefully removed.
The bladder of all rats was expressed to collect terminal urine
samples formed during the timed intervals of arterial constriction.
Terminal urine samples were collected to determine the sodium concen
tration as described below.
The designated animals, one-kidney and two-kidney models had
blood samples collected at the following timed intervals: 10, 30, 60,
and 90 min. Blood samples were collected from individual rats at the
end of each timed interval.
In normotensive, SHR's, and Wistar control rats, blood samples
for plasma renin activity were taken immediately after the aorta and
vena cava were dissected free (zero time). Anephric controls had both
kidneys removed 24 hrs prior to the collection of blood samples.
One-kidney ischemic model
The right kidney of 40 experimental Sprague-Dawley rats (141-358 g),
10 for each timed interval was removed,and the left renal artery
partially constricted. Control rats had the right kidney removed and
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the left renal artery was left intact (Fig. 1). Five control rats were
used for each timed interval.
Two-kidney ischemic model
The right kidney of 40 rats (Sprague-Dawley) weighing between
192 and 390 g was left intact and the left renal artery constricted as
shown in Fig. 2. The controls consisted of 5 animals (Sprague-Dawley),
per timed interval, with an incision along the linea alba, with both
kidneys intact and not manipulated. The aorta and vena cava were
dissected free of connective tissue and after the elapsed timed interval,
they were cut in order to rapidly collect the blood.
Normotensive and anephric rats
Normotensive rats (Sprague-Dawley) consisted of 10 animals
(230-334 g) with both kidneys intact. The anephric rats (Sprague-Dawley)
were composed of 9 animals (209-397 g) that had both kidneys surgically
removed 24 hrs prior to the collection of plasma samples. The removal
of the kidneys eliminated the major renin source.
Spontaneous hypertensive rats
SHR's (Wistar) consisted of 11 animals between the 28-38 weeks
(243-285 g). In these animals both kidneys were intact. Five normo
tensive (Wistar) rats (220-316 g) of approximately the same age with
both kidneys intact were used as controls.
Blood pressure measurement
All experimental and control rats had their normal blood pressure
measured and recorded 24 hrs prior to surgery. The animals were placed
in a warming system at 34-37 C for about 15 min before recording the




of blood in the caudal artery. Blood pressure was measured from the
tail using a programmed electrosphygomomanometer connected to a
pneumatic pulse transducer. The mean of 10 recorded pressures was taken
as the final blood pressure of each rat.
Collection of blood for sodium determination
An initial blood sample was collected from each rat in non-
heparinized capillary tube by puncturing the caudal artery with a sharp
razor blade. The blood was centrifuged, then the plasma was decanted
and stored frozen (-15 C) until used for analysis as described below.
Collection of blood for plasma renin activity (PRA)
Systemic blood was collected by severing the aorta and vena cava
simultaneously and allowing the animal to bleed into a chilled beaker
containing 0.5 ml of 0.3 M EDTA. The blood was centrifuged at 4 C
(2500 rpm) for 15 to 20 min. A 0.1 ml aliquot of plasma was removed
from the centrifuged tube to be used in the determination of terminal
sodium. Plasma samples for both sodium determinations and PRA were
stored frozen (-15 C) until used for analysis as described below.
Determination of sodium, urine and plasma
All samples for sodium determination were assayed according to a
protocol published by Perkin-Elmer Corp. (1971) for flame emission
analysis using an atomic absorption spectrophotometer (Model 107). Urine
and plasma samples were diluted 1:50 with deionized water. The concen
tration was expressed as mEq/1.
Determination of plasma renin activity
Plasma renin activity was determined using the New England Nuclear
protocol and angiotensin-I (*2^l) radioimmunoassay kit (1973). A brief
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outline of modifications made in the protocol by this laboratory are as
follows:
1. Maleate buffer concentrate (25 ml) used for the generation of
angiotensin-I was diluted to approximately 200 ml with dis
tilled water and adjusted to pH 6.5 with 14 ml of 5N sodium
hydroxide. New England Nuclear's protocol suggests a pH of
6.0 as the optimum pH for angiotensin-I generation in human
plasma samples. Boucher et al. (1967) reported that pH 6.5
was the optimum pH for angiotensin-I generation for rat plasma.
The protocol was modified to take advantage of the 6.5 pH for
maximum generation of rat angiotensin-I.
2. New England Nuclear (1973) suggests 10 microliters of
dimercaprol solution and 10 microliters of 8-hydroxyquinoline
solution as inhibitors of the plasma converting enzyme and the
enzymatic proteolysis of angiotensinases. In this investiga
tion 25 microliters of each inhibitor was used to ensure com
plete inhibition of plasma angiotensinases (Elebute, 1974).
Additional inhibitors appear to have no affect on the genera
tion of angiotensin-I.
All samples were done in duplicate and counted in sequence for
2 min in a liquid scintillation system. The third channel (C channel)
was used and the counting efficiency was approximately 60%.
Plasma renin activity was expressed as ng/ml/hr of generated
angiotensin-I.
Kidney weight
At the termination of each experiment, all kidneys were removed
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and weighed on a Sartorius balance with a sensitivity of ± 0.001 mg.
The mean kidney weights were recorded for SHR's, Wistar controls and
normotensive rats. Individual weights were taken for the right and
left kidneys, of all two-kidney ischemic animals, and the left kidneys




Part of the experimental data was statistically analyzed at the
Atlanta University Computer Center using an IBM Computer (Model 1130).
The programs used were the Distribution statistics (D01) and T-Tests for
independent means and F-Tests for homogeneity of independent variances
(V06). The remaining data was calculated using an Olivetti programmable
microcomputer (Model P-652).
For clarity and brevity, all timed intervals of renal artery con
striction are expressed as T1Q, T3Q, Tg0 and Tgo* Each timed interval,
in most cases, represents 10 experimental and 5 control rats in which
the left renal artery was constricted or remained intact for the
designated test period. In addition, all rat groups are of the
Sprague-Dawley strain unless specified (graphs and tables).
Anephric rats
The plasma renin activity (PRA) of anephric rats was significantly
decreased (p < .05) when compared with normotensive Sprague-Dawley rats
as shown in Fig. 3. There was significance of the variance between the
standard deviation (p = 0.0009); therefore, the data in Fig. 3 confirm
the validity of the assay procedure.
One-kidney ischemic rats
Figure 4 shows that the PRA is significantly different for only
the T10 group. In the T^q test rats the mean PRA was significantly
lower than that for the T10 control rats (7.28 ± 1.97 vs. 18.44 ± 3.86
ng/ml/hr, p < .05). In the other timed intervals, there was no
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Fig. 3. Plasma renin activity (PRA) in anephric and normotensive
rats. The assay procedure was verified by this data.
A significant increase in PRA was seen when anephric
and normotensive rats were compared (0.00 ± 0.00 vs.
11.068 ± 1.347 ng/ml/hr, p < .05). Vertical bars
represent ± SE.
A - Anephric rats















Fig. 4. Plasma renin activity (PRA) in one-kidney ischemic rats.
One-kidney test rats had the left renal artery con
stricted with the contralateral kidney removed. One-
kidney control rats had no left renal artery constriction.
However, the contralateral kidney was removed. A
significant difference between test and control rats
was seen only at 10 min constriction of the left renal




















significant aurerence between the
Q m 4^ *^ aIb -_ — _a~ JP • - x
activity) in the
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T60 group. Also of interest was the significant decrease in PRA in the
T90 group in relation to the peak activity seen in the T6£) group
(P < .05).
Endogenous levels of angiotensin-I (A-I) in one-kidney control
and experimental Sprague-Dawley rats revealed no significant increase
(P > .05) as shown in Fig. 5. Timed intervals (T^ through !„> showed
increases in endogenous A-I. The greatest increase was at T60 (controls,
4.19 ± 0.89; experimental, 5.56 ± 0.98 ng/ml/hr). There was a
reduction in endogenous A-I at T9Q (controls, 2.75 ± 0.47; experimental,
2.95 ± 0.88 ng/ml/hr). Only the T9Q group revealed a significance of
the variance between the standard deviation, p = 0.0210 (Fig. 5).
The PRA in normotensive Sprague-Dawley rats was compared with that
of one-kidney ischemic control rats as shown in Fig. 6. All control
groups revealed a significant increase in generated PRA as compared with
normotensive rats (p < .05). Generated PRA increased per timed interval,
TlO trough T6Q but decreased in the T9Q group. Only the T6Q group
showed a significance of the variance between the standard deviation
(p - 0.0155).
The PRA in normotensive and one-kidney ischemic test rats is
shown in Fig. 7. A11 tlmed groups except ^ ^ ^^ ^^ ^
significant increase in generated PRA (Tlo. p > .05; 1^ through T9Q,
P < .05). In addition, all timed groups except the T1Q rats showed a
significance of the variance between the standard deviation (T1Q>
P = 0.1364; T30, p = 0.0008; T60, p = 0.0004; T90. p = 0.0032)!°
Fig. 5. Endogenous plasma angiotensin-I in one-kidney ischemic
rats. The endogenous A-I is indicative of in vivo
renin activity. No significant difference was seen
when test and control rats were compared at any timed

































9 V O ■ o 0
1
■
o v o o 0
1
Fig. 6. Plasma renin activity (PRA) in normotensive and one-
kidney ischemic control rats. One-kidney control
rats had no left renal artery constriction, but the
contralateral kidney was removed. A significant
increase in PRA was seen at all timed intervals when
normotensive and one-kidney control rats were
compared (p < .05). Vertical bars represent ± SE.
A - Normotensive rats


















Fig. 7. Plasma renin activity (PRA) in normotensive and one-
kidney ischemic test rats. One-kidney test rats had
the left renal artery constricted with the contra-
lateral kidney removed. Significant increases in
PRA were seen in all groups except 10 min constriction
of the left renal artery. Vertical bars represent ± SE.
A - Normotensive rats
B through E - One-kidney ischemic test rats





















As seen in Table 1, the initial and terminal sodium concentrations
in the urine of one-kidney ischemic rats are quite variable in control
and experimental groups and in all cases the terminal urine sodium was
lower. Initial urine collections were for six hours whereas terminal
urine was collected at the end of each timed interval (T1Q through T9Q).
Table 2 shows the initial and terminal sodium concentrations in
the plasma of one-kidney ischemic rats, The data show that the initial
plasma sodium in the control and experimental rats is within a narrow
standard deviation and within the normal range of plasma sodium as
supported by data obtained in this study, The terminal plasma sodium
however shows a greater standard deviation due to sodium contamination
with sodium EDTA,
Two-kidney ischemic rats
Figure 8 compares the PRA in the two-kidney system, No signifi
cant differences were seen at any timed interval and there was no
significant difference of the variance between the standard deviation
of individual groups when test animals were compared with controls.
Figure 8 also shows that there is an overall increase in PRA in controls
and experimental groups as the timed interval increased (T1Q controls,
13,25 ± 3.30; T1Q test, 25.69 ± 4.44; T9Q controls, 69.94 ± 17.41$ T90
test, 56.40 ± 8.99 ng/ml/hr).
Endogenous A-I in the plasma of our two-kidney system was not
significantly different when controls and test animals of individual
timed intervals were compared (p > ,05), However, a composite of the
groups shows that there was a significant increase in A-I in the TgQ
group when compared with all other groups. For example, in the T-^q
group, the A-I was 1,86 ±0,55 for controls and 1,97 ± 0,49 ng/ml/hr for




J5L 10 (N) 30
Time in minutes
(N) 60 (N) 90
Initial
Controls 4 84.45 ± 61.92a 5 101.27 ± 59.41 5 156.35 ± 89.37 5 204.60 ± 57.60
to
Experimentals 10 106.57 ± 53.36 9 177.02 ± 89.39 10 133.51 ± 77.18 11 274.71 ± 99.24
Terminal
Controls 4 72.67 ± 61.22 4 89.62 ± 51.94 4 74.17 ± 42.98 5 69.16 ± 33.13
Experimentals 7 75.50 ± 27.43 6 83.02 + 37.51 7 68.08 + 22.03 12 58.21 ± 22.39
a± SD = Standard deviation of the mean.
All values represent the mean for the number (N) of rats assayed in each timed interval.





10 (N) 30 (N) (N)
Initial
Controls 4 142.84 ± 7.31a
Experimentals 10 145.73 ± 10.29
3 141.19 ± 10.60 2 136.50 ± 7.47 4 137.16 ± 6.23
ro
8 148.48 ± 10.10 9 135.15 ± 8.57 10 147.39 ± 15.02
Terminal
Controls 4 154.38 ± 21.60 5 159.70 ± 24.16 4 154.46 ± 37.11 4 152.42 ± 34.42
Experimentals 8 148.47 ± 14.28 10 163.17 ± 24.00 8 145.40 ± 31.91 9 133.17 ± 28.34
a ± SD = Standard deviation of the mean.
All values represent the mean for the number (N) of rats assayed in each timed interval.
Fig. 8. Plasma renin activity (PRA) in two-kidney ischemic
rats. Two-kidney test rats had constriction of the
left renal artery with the contralateral kidney
unmanipulated. Surgery was performed on control
rats with no manipulation of the kidneys. No
significant differences were seen at any timed





























the test animals. In the T group the controls had an A-I of 4.58 ±
1.74 and the test, 4.80 ± 1.08 ng/ml/hr (Fig. 9).
The PRA in normotensive and two-kidney ischemic control rats is
shown in Fig. 10. Only the T^q controls revealed no significant differ
ence of the mean between normotensive and two-kidney control rats
(p > .05). In all other control groups there was a significant increase
in PRA (p < .05). A significant difference of the variance between the
standard deviation was seen in all groups (p < .05) except the T..
control rats (p = 0.0786; p > .05).
Figure 11 shows the PRA in normotensive and two-kidney test
Sprague-Dawley rats. A significant increase in PRA was seen at all
timed intervals (p < .05) when the two-kidney test animals were compared
to normotensive animals. A significant difference of the variance
between the standard deviation (p < .05) was also observed at all timed
intervals when the PRA of two-kidney ischemic experimental rats was
compared to that of normotensive rats.
As seen in Table 3, the initial urine sodium in two-kidney
ischemic control and experimental Sprague-Dawley rats show an over
lapping standard deviation. The initial urine sodium concentrations
are quite variable in control and experimental rats prior to arterial
constriction. Terminal urine sodium was lower than initial urine
sodium in all groups. For example, initial urine sodium was as follows:
T1Q controls, 181.61 ±43.00; T10 test, 193.89 ± 61.29; in comparison,
the terminal urine sodium was: T1Q controls, 77.97 ± 39.68; T10 test»
84.42 ± 23.46 mEq/1. The time of collection of urine should again be
noted; initial collections were for six hours and terminal urine
Fig. 9. Endogenous plasma angiotensin-I in two-kidney ischemic
rats. The endogenous A-I is indicative of Jji vivo
renin activity. No significant increase in endogenous
A-I was seen at any timed interval when test and
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Fig. 10. Plasma renin activity (PRA) in normotensive and two-
kidney ischemic control rats. Controls had surgery
performed with no manipulation of the kidneys. No
significant increase in PRA was seen at 10 min
(p > .05). However, all other timed intervals
showed a significant increase in PRA when normoten
sive and two-kidney ischemic control rats were
compared (p < .05). Vertical bars represent ± SE.
A - Normotensive rats























Fig. 11. Plasma renin activity (PRA) in normotensive and
two-kidney ischemic test rats. Two-kidney ischemic
test rats had the left renal artery constricted with
the contralateral kidney unmanipulated. Significant
increases in PRA were seen at all timed intervals
when normotensive and two-kidney ischemic test rats
were compared (p < .05). Vertical bars represent ± SE.
A - Normotensive rats























Table 3. Initial and terminal sodium concentration in the urine of two-kidney ischemic rats.
Urine Na+
in
mEq/liter Time in minutes
(N) 10 (N) 30 (N) 60 (N) 90
Initial
Controls 5 181.61 ± 43.00a 5 98.08 ± 93.80 5 145.08 ± 36.15 5 54.41 ± 27.93
Experimentals 10 193.89 ± 61.29 8 136.04 ± 64.46 10 152.15 ± 47.70 8 64.34 ± 37.60
Terminal
Controls 5 77.97 ± 39.68 3 110.68 ± 56.51 5 61.54 ± 52.85 5 62.04 ± 31.56
Experimentals 10 84.42 ± 23.46 8 89.19 ± 41.67 10 74.68 ± 36.87 8 91.78 ± 70.89
a ± SD = Standard deviation of the mean.




collections were 10 through 90 minutes.
In Table 4, the initial and terminal sodium in the plasma of two-
kidney ischemic Sprague-Dawley rats is summarized. There is a narrow
standard deviation in initial plasma sodium in control and test groups.
For example, initial plasma sodium for controls was: T10, 147.98 ± 13.14;
T30, 142.50 ± 8.64; T6Q> 139.00 ± 8.89; T9Q, 148.07 ± 12.17. In com
parison, the initial plasma sodium for test animals was as follows:
Tlo, 150.55 ± 9.31; T30, 150.30 ± 12.76; T6Q, 137.17 ± 15.91; T9Q,
148.45 ±:11.33 mEq/1. These values are within the normal range of rat
plasma sodium concentration. However, the terminal sodium in the plasma
of control and experimental rats reveal a high sodium level with an
overlapping standard deviation due to contamination with sodium EDTA.
A composite of PRA data for control and test rats (Fig. 12) was
compared for significance between the one-kidney and two-kidney systems.
Interestingly, a significant difference of the mean (p = 0.0016, p < .05)
and a significance of the variance between the standard deviation
(p = 0.0124, p < .05) was exhibited by T1Q one-kidney test rats vs.
TlQ two-kidney test rats. PRA values were 7.28 ± 1.97 vs. 25.69 ± 4.44
ng/ml/hr for T1Q one-kidney and two-kidney test animals respectively.
The T9Q one-kidney test rats vs. T9Q two-kidney test animals revealed
a significance of the mean (p = 0.0005, p < .05) and a significance of
the variance between the standard deviation (p = 0.0002, p < .05). PRA
values shown were 18.43 ± 2.35 vs. 56.40 ± 8.99 ng/ml/hr for TQQ one-
kidney and two-kidney test animals, respectively. All other comparisons
between test animals of the two systems (T3Q and Tg0) revealed no
significant change (p > .05).
Table 4. Initial and terminal sodium concentration in the plasma of two-kidney ischemic rats.
Urine Na+
in Time in minutes
mEq/liter
(N) 10 (N) 30 (N) 60 (N) 90
Initial
Controls 5 147.98 ± 13.14a 5 142.50 ± 8.64 5 139.00 ± 8.89 5 148.07 ± 12.17
Experimentals 9 150.55 ±9.31 9 150.30 ± 12.76 10 137.17 ± 15.91 8 148.45 ± 11.33
Terminal
Controls 5 176.75 ± 17.60 4 203.89 ± 13.73 4 195.61 ± 24.03 2 158.73 ± 27.20
Experimentals 7 182.52 ±30.18 9 188.81 ± 26.10 10 182.03 ±40.69 7 169.22 ± 26.06
a ± SD = Standard deviation of the mean.
All values represent the mean for the number (N) of rats assayed in each timed interval.
Fig. 12. Comparison of plasma renin activity (PRA) in one-kidney
and two-kidney Goldblatt (Sprague-Dawley) rats. One-
kidney experimental rats had left renal artery constric
tion with the contralateral kidney removed. The one-
kidney control rats had the contralateral kidney removed
with no constriction of the left renal artery. Two-kidney
experimental rats had left renal artery constriction with
the contralateral kidney intact. The two-kidney control
rats had surgery performed with no kidney manipulation.
O One-kidney Goldblatt experimental rats
® One-kidney Goldblatt control rats
A Two-kidney Goldblatt experimental rats











10 30 60 90
TIME (min)
37
T,jq one-kidney controls vs. T^q two-kidney controls (Fig. 12)
exhibited a significant difference of the mean (p = 0.0069, p < .05)
and a significance of the variance (p = 0.0002, p < .05). PRA values
were 20.59 ± 1.70 vs. 69.94 ±17.41 ng/ml/hr for Tgo one-kidney and
two-kidney control rats, respectively. The remaining controls (T,n,
TgQ and Tgg) showed no significance of the mean or variance (p > .05).
Figure 13 shows the correlation between PRA and blood pressure
(B/P) in spontaneous hypertensive rats (SHR, Wistar strain), normoten-
sive Wistar rats and normotensive Sprague-Dawley rats. No significance
of the mean was seen between SHR's and normotensive Sprague-Dawley
rats (p > .05). A significance of the mean was observed between
normotensive Wistar rats and SHR's (p < .05). No significance of the
variance between the standard deviation was seen between any of the
above groups (p > .05).
Data in Fig. 13 also demonstrate that the mean indirect B/P may
be independent of PRA. The mean B/P and indirect PRA values are as
follows: SHR's, B/P of 182.11 ± 6.28 mm Hg; PRA 12.15 ± 1.48 ng/ml/hr;
Normotensive Wistar rats, B/P of 94.74 ± 3.24 mm Hg; PRA of 20.61 ± 1.92
ng/ml/hr. In comparison, the normotensive Sprague-Dawley rats had a
mean B/P of 115.61 ± 2.31 mm Hg compared to a PRA of 11.06 ± 1.34
ng/ml/hr.
As shown in Table 5, the sodium concentration in the plasma of
SHR's, Wistar controls, normotensive Sprague-Dawley and anephric
control (Sprague-Dawley) rats is within the normal range of rat plasma
sodium. The SHR plasma sodium was 154.32 ± 11.11 mEq/1 as compared to
136.51 ± 10.25 mEq/1 for the Wistar controls. Sprague-Dawley rats,
Fig. 13. A graph of plasma renin activity (PRA) and blood
pressure (B/P) in spontaneous hypertensive rats (SHR,
Wistar strain), normotensive Wistar rats and normo
tensive Sprague-Dawley rats. No significant increase
in PRA was seen when SHR's and normotensive Sprague-
Dawley rats were compared (p > .05). A significant
increase in generated PRA was seen when normotensive
Wistar control rats were compared to SHR's (p < .05).
SHR - Spontaneous hypertensive rats
WS - Normotensive Wistar rats





























Table 5. Sodium concentration in the plasma and urine of











11 154.32 ± 11.II1
5 136.51 ± 10.25
10 140.54 ± 8.94
9 146.66 ± 17.66
11 142.78 ± 63.78
144.90 ± 71.39
10 99.15 ± 79.97
223.46 ± 119.30
a Plasma and urine were taken prior to nephrectomy.
k ± SD = Standard deviation of the mean.
All values represent the mean for the number (N) of rats assayed.
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both normotensive and anephric controls (prior to nephrectomy) had
plasma sodium concentrations of 140.54 ±8.94 and 146.66 ±17.66 mEq/1,
respectively.
Table 5 also shows the sodium in the urine of all four groups of
rats to be highly variable (see standard deviations). The SHR's urine
sodium was 142.78 ± 63.78 vs. 144.90 ± 7.139 mEq/1 for the Wistar
control rats. Normotensive and anephric control Sprague-Dawley rats
(prior to nephrectomy) had urine sodium of 99.15 ± 79.97 and 223.46 ±
119.30 mEq/1, respectively.
Mean kidney weights of one-kidney ischemic Sprague-Dawley rats
are shown in Table 6. There was an insignificant variation in the
% body weight of the left kidney in the one-kidney control vs. the
one-kidney test Sprague-Dawley rats. The % body weights for one-kidney
control vs. one-kidney test rats for the timed intervals of T10, T30,
T60, and T9Q were: 0.389 vs. 0.372; 0.395 vs. 0.406; 0.332 vs. 0.358;
and 0.356 vs. 0.402, respectively.
It was confirmed that the left kidney in the two-kidney system
Sprague-Dawley rats increased in % body weight as the timed interval
increased (Table 7). This increase in left kidney % body weight for
experimental rats was 0.348, 0.341, 0.378, and 0.401 for T1Q, T3Q, 1
and T90 constriction of the left renal artery, respectively. The %
body weight of the right kidney was within a range of 0.333 to 0.337
for T1Q through T9Q constriction, respectively.
The % body weight of the left kidney of the two-kidney Goldblatt
Sprague-Dawley rats within a range of 0.302 to 0.342 for T1Q through
T90 controls. The right kidney % body weight ranged between 0.305 and
0.342 for 10 through 90 minutes controls.
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5 0.81 ± 0.041a (0.389) 10 0.73 ± 0.03 (0.372)
5 0.70 ± 0.03 (0.395) 10 0.73 ± 0.05 (0.406)
5 0.98 ± 0.07 (0.332) 10 0.95 ± 0.04 (0.358)
7 0.94 ± 0.03 (0.356) 12 1.10 ± 0.06 (0.402)
a ±SD = Standard deviation of the mean.
N = Number of rats used in determinations for each timed interval.
Number in parentheses represents the percent body weight.










10 5 1.05 ± 0.03 (0.302)
30 5 1.05 ± 0.04 (0.328
60 5 1.00 ± 0.06 (0.316)
90 5 1.04 ± 0.06 (0.342)
1.06 ± 0.04 (0.305) 10
1.06 ± 0.07 (0.331) 9
1.06 ± 0.09 (0.335) 10
1.04 ± 0.07 (0.342) 11
1.15 ± 0.05 (0.348) 1.10 ± 0.06 (0.333)
1.15 ± 0.05 (0.341) 1.11 ± 0.04 (0.329)
1.21 ± 0.05 (0.378) 1.06 ± 0.04 (0.331)
1.19 ± 0.05 (0.401) 1.00 ± 0.03 (0.337)
L = Left kidney
R = Right kidney
N = Number of rats used in determinations for each timed interval.
a + SE = Standard error of the mean.
Number in parentheses represents the percent body weight.
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The mean kidney weights with changes in PRA and B/P in normoten-
sive Wistar controls, SHR's and normotensive Sprague-Dawley rats is
demonstrated in Table 8. The % body weight contributed by the mean
kidney weight of SHR, Wistar controls and normotensive Sprague-Dawley
rats was 0.331, 0.307, and 0.361, respectively. There appear to be no
correlations between the % body weight of the kidneys and PRA in these
groups of rats. SHR's were characterized by a high B/P, 182.109 ±6.28
mm Hg vs. a reduced or normal PRA, 12.155 ± 1.482 ng/ml/hr. The Wistar
controls exhibited a normal B/P, 94.74 ± 3.237 mm Hg vs. a PRA of
20.615 ± 1.928 ng/ml/hr. Normotensive Sprague-Dawley rats had a B/P
of 115.159 ± 2.315 mm Hg vs. a PRA of 11.068 ± 1.347.
Table 8. A comparison of mean kidney weights with changes in plasma renin activity and blood
pressure in normotensive and spontaneous hypertensive rats.
Strain N Weight in grains PRA ng/ml/hr Blood pressure mm Hg
SHR
Wistar controls
11 0.894 ± 0.015 (0.331) 12.155 ± 1.482
5 0.815 ± 0.045 (0.307) 20.615 ± 1.928




a ± SE = Standard error of the mean.
N = Number of rats used in determinations.
Number in parentheses represents the percent body weight.
CHAPTER V
DISCUSSION
It is generally accepted that the renin-angiotensin system plays
an important function in renal hypertension in experimental animals
(Kumar and Deodhar, 1973). It also plays a major role in the normal
regulation of salt and water metabolism through its control of aldos-
terone secretion by the adrenal cortex. Therefore, the laboratory
determinations of renin have become important in studying hypertension
due to renal artery disease or aldosterone hypersecretion.
Evidence is accumulating to indicate that angiotensin exerts an
important direct regulatory control over arterial blood pressure under
a variety of normal physiological states via its vasoconstrictor actions.
Moreover, evidence has also indicated that the renin-angiotensin system
initiates the elevation of blood pressure that follows renal artery
constriction (Goldblatt et al., 1934). This reduction in blood pro
fusion pressure as produced by an arterial clip may enhance renin
secretion by the kidneys (Regoli et al., 1961). Thus, it appears well
established that radical alterations in the normal hemodynamics of the
kidney may produce experimental hypertension.
The present experiments were performed for the following; To
qualify plasma renin activity (PRA) in acute renal ischemia (at the
onset of reduced kidney blood profusion pressure, 10 through 90 min)
in one-kidney and two-kidney ischemic rats; to test the validity of the
radioimmunoassay (RIA) for this laboratory; and finally, to confirm




The validity of the RIA experiments was confirmed based on the data
in Fig. 3. The PRA values of nephrectomized rats were significantly
lower (p < .05) than those of normotensive Sprague-Dawley rats. Recent
data of angiotensin-I generated from the plasma of normotensive Sprague-
Dawley rats under similar experimental conditions have given values sup
portive of those obtained in the present study by RIA (Menard and Catt,
1972).
Peripheral plasma levels of renin have been studied by many investi
gators (Gollan et al., 1948; Scornik and Paladini, 1961; Mulrow, 1965).
Pritchard et al. (1964) assayed plasma for pressor activity during differ
ent phases of experimental renal hypertension in dog. They found in
creased pressor material only during the first two weeks after renal
artery constriction. Koletsky and Pritchard (1963), in their studies,
indicated that acute renal hypertension causes the appearance of a sub
stance in the arterial blood of hypertensive rats which causes a rise
in blood pressure when injected into normal rats. The rats in this
study developed hypertension promptly, i.e., within several hours after
renal injury, and the development of high blood pressure coincided with
the appearance of a vasoconstrictor substance in the blood.
Skinner et al. (1963) found that within five to fifteen min after
renal artery constriction, there was a slow rise in arterial pressure.
The rise was accompanied constantly by the appearance of considerable
pressor activity in renal venous blood and the lesser amount of activity
in arterial blood.
The results of this study confirm the above. The PRA of normo
tensive Sprague-Dawley rats was 11.068 ± 1.347 ng/ml/hr. The PRA of all
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experimental rats of both systems with the exception of 10 min one-kidney
Goldblatt hypertensive rats (Figs. 7, 11) were significantly higher
(p < .05). In addition, control rats in both systems, with the exception
of T^q two-kidney ischemic control rats, revealed a significantly higher
PRA (p < .05) than the normotensive rats (Figs. 6, 10).
In the one-kidney system (Fig, 4) only the T^q group showed a
significant difference of the mean in PRA (p < .05). All other rats re
vealed an insignificant difference of the mean in PRA (p < ,05). However,
both systems were characterized by an increase in PRA as the timed inter
vals increased. The exception was the Tqq rats; they showed a moderate
decrease in PRA.
It is very apparent that a marked PRA increase occurs in both
systems, experimental and control rats. In all cases renal artery con
striction was performed under anesthesia. It is known that both anes
thesia and surgery may influence PRA (McKenzie et al., 1967), renal
sodium excretion (Blake, 1957), and plasma volume (Reike and Everett,
1957). It is highly probable that surgery and anesthesia influenced
the observed PRA values.
Circulating angiotensin-I increased in concentration from 10
through 90 min in both experimental systems for all animal groups
(p < .05). The one-kidney system was characterized by the T-.Q control
rats having a moderately higher level of angiotensin-I than their
experimental counterparts. Sixty min experimental rats exhibited the
greatest increase of circulating angiotensin-I, with a reduction at
Tqq in both experimental and control rats (Fig. 5). Experimental rats
showed a moderate increase in circulating angiotensin-I vs. control
rats in the two-kidney system (Fig. 9). This increase of circulating
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angiotensin-I may well be an attempt to regulate or control blood
pressure under the given experimental conditions.
A physiological response to aldosterone in mammalian target tissue
shows a latent period before the effect of active sodium transport is
observed. The time period of approximately 45 min to 1 hr in the kidney
and extrarenal target tissues in mammals is well documented (Barger
et al., 1958; Coghlan et al., 1960; Fimognari et al., 1967).
This consistent finding in the kidney is indicative of data in
Table 1. Terminal urine sodium concentration of the T«q one-kidney
group when compared to other groups of this system show a reduction in
sodium excreted. This may be an indication of sodium retention.
A number of different conditions are known to enhance the produc
tion and secretion of renin in the kidney. The control stimulus respon
sible for stepping up renin production remains unknown. It has been
tentatively identified with decreased perfusion pressure (Skinner et
al., 1963).
A comparison of terminal urine data in Tables 1 and 3 reveals
that terminal urine sodium concentration in all two-kidney experimental
rats was greater than their one-kidney counterparts. In the rat, con
striction of one renal artery, with removal of the contralateral kidney
leads to an impairment to elaborate a concentrated urine (Gross et al.,
1964). This finding is in apparent contrast to the well known observa
tion that constricting the renal artery in a dog in water diuresis may
induce the production of an isotonic or even slightly hypertonic urine
(Berliner and Davidson, 1957). Differences in the species and in the
degree of constriction may be responsible for the apparent opposite
effects. The same decrease in renal blood flow and in GFR may have
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opposite effects on the diluting and the concentrating mechanism
(Gross et al., 1964).
The spontaneous hypertensive rat (SHR) provides a useful model for
studying hypertension, although the etiology of the mechanism respon
sible for the development of the high blood pressure in these animals
is still not known. The renin-angiotensin system of SHR's was investi
gated in the present study. The role of this system is especially
important because spontaneous hypertension in the rat appears to
resemble human benign essential hypertension more closely than other
types of experimentally induced high blood pressure.
SHR investigations have revealed conflicting results regarding the
renin-angiotensin system. Some studies suggest that the renin-angioten
sin system is important only in the development of spontaneous hyperten
sion (Sen et al., 1972; DeJong et al., 1972). Recent evidence has shown
that renin activity in SHR's is reduced or within normal limits at
approximately the time when blood pressure elevation ensues (Sokabe,
1966). Renin activity has been shown to be significantly lower in SHR's
(p < .05) than in control rats when older animals were compared (McKenzie
and Phelan, 1969; Gresson, 1972). Perhaps, increased renin activity is
only required in the early stages to establish a pattern which is main
tained throughout later life (Sinaiko and Minkin, 1974).
The results of this study (Fig. 13, Table 8) indicate that the PRA
of SHR's in the well-developed stage of high blood pressure (33.09 ± 1.14
weeks of age), is significantly reduced (p < .05) or within normal limits
(Koletsky et al., 1970; Sokabe, 1965, 1966) when compared to normotensive
Wistar control rats. This study confirms that the maintenance of the
50
well-developed stage of high blood pressure in SHR's is not due to in
creased activity of the renin-angiotensin system (Sokabe, 1965; Koletsky
et al., 1970).
Gresson (1972) found that lower renin levels in the New Zealand
strain of rats with genetic hypertension (GH rats) was not secondary to
increased total body sodium levels. Further, the finding of lower body
sodium levels argues by inference, against increased mineralocorticoid
activity in GH rats. In addition, Gresson (1972) found no difference
in plasma sodium concentration. Results of this study revealed no basic
differences of plasma sodium concentrations in SHR's, Wistar controls,
normotensive Sprague-Dawley's and anephric control rats (Table 5).
Kidney weight (clamped kidney) whether expressed as gram of kidney
or per 100 gram of body weight was shown not to influence PRA (Table 6,
8). PRA was lower in SHR's, although the differences were not signifi
cant in all groups. The two experimental systems showed variation in
PRA between individual rats. Variation between individual rats was much
less in the highly inbred hypertensive strain than in the other groups.
The two-kidney ischemic experimental rats (with the exception of
Tjq animals) revealed an increase in the gram weight and the % body
weight of the constricted left kidney as the timed intervals increased
(Table 7). There was not an increase in the left kidney gram weight
in the control rats. Since the permeability of the clamped kidney is
reduced, it is highly probable that increased sodium reabsorption is
responsible for the increased kidney weight or % body weight (Gross
et al., 1965; Botticelli and Lange, 1964).
Initial sodium concentrations in the plasma of one-kidney and
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two-kidney ischemic rats were found to be within the normal range
(Tables 2, 4). However, terminal sodium concentrations reflect the
probability of sodium contamination (sodium EDTA), as noted from over
lapping concentration values and standard deviations between groups.
CHAPTER VI
SUMMARY
From the present investigation, it is concluded that:
1. The assay procedure for plasma renin activity (PRA) was
validated by a comparative analysis of plasma from anephric
and normotensive Sprague-Dawley rats.
One-kidney system
2. PRA of T,Q one-kidney test rats was significantly lower
than that for the T1Q control rats. All other timed
intervals exhibited no significant increase in PRA when
test and control groups were compared.
3. PRA exhibited peak activity in the Tg0 group.
4. Endogenous angiotensin-I (A-I) in the one-kidney system
revealed no significant increases. However, the Tfi0 group
showed the greatest increase in A-I, with a reduction in
A-I at T9Q.
5. All one-kidney control groups revealed a significant
increase in generated PRA when compared to normotensive
rats.
6. All one-kidney test groups with the exception of the T^Q
rats had a significant increase in PRA as compared to normo
tensive rats.
7. The initial and terminal sodium concentrations in the urine
of the one-kidney system was quite variable in control and




8. Initial plasma sodium in the one-kidney system was within
normal limits.
Two-kidney system
9. There was no significant increase in PRA at any timed interval
when the test and control groups were compared in the two-
kidney system.
10. Endogenous A-I was not significantly different when test and
control rats of individual timed intervals were analyzed. A
composite of the groups shows that there was a significant
increase in A-I in the T^q group when compared to all other
groups.
11. With the exception of the T^q control group, all two-kidney
system control groups had a significant increase in PRA
when paired with normotensive animals.
12. A significant increase in PRA was seen at all timed intervals
when the two-kidney test groups were compared to normotensive
rats.
13. Initial urine sodium in the two-kidney system had an over
lapping standard deviation. Terminal urine sodium was lower
than initial urine sodium in all groups except the Tqn group.
14. A comparison of the terminal urine sodium of the one and
two-kidney systems shows that the one-kidney system had a
decreased ability to form a concentrated urine.
15. Initial plasma sodium in the two-kidney system was within
the normal range.
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16. A composite of PRA for the one-kidney and two-kidney systems:
The T1Q two-kidney test group exhibited a significant in
crease in PRA when compared to T1Q one-kidney test animals.
The Tqq two-kidney control group showed a significant
increase in PRA as compared to the Tqq one-kidney group.
17. No significant increase in PRA was seen between spontaneous
hypertensive rats (SHR's) and normotensive Sprague-Dawley
rats. There was a significant increase in PRA when SHR's
and normotensive Wistar rats were compared.
18. Mean indirect blood pressure (B/P) may be independent of PRA
in SHR's. In addition, the associated high B/P of SHR's
may function independently of the renin-angiotensin system.
19. Plasma sodium of SHR's, normotensive Wistar controls and
normotensive Sprague-Dawley rats was within normal limits.
The above groups had a highly variable urine sodium concen
tration with an overlapping standard deviation.
20. Mean kidney weights of the one-kidney system had an in
significant variation in the % body weight of the left
kidney when the test and control groups were compared.
21. The left kidney of the two-kidney test group showed an
increase in % body weight as the timed interval increased.
The right kidney did not reveal an increase in % body weight.
22. The left nor right kidney of the two-kidney control rats
increased in % body weight as the timed intervals increased.
23. The mean kidney weights of SHR's, normotensive Wistar controls
and normotensive Sprague-Dawley rats exhibited no correlations
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between the % body weight and PRA.
The above conclusions support the treatise that the renin-angio-
tensin system reacts promptly to certain stimuli (renal ischemia,
surgery and anesthesia) by an increase renin release and consequently
an elevation of renin activity in the blood. The comparison of the
one-kidney and two-kidney systems with normotensive Sprague-Dawley
rats substantiates the above.
Rather than the renin-angiotensin system being considered as an
entirely pathologic condition, evidence suggests that it is probably
a mechanism that can cause serious malfunctions in the cardiovascular
system when regulation becomes impaired.
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